Glp-1 drugs and 'Ozempic personality': when weight loss comes with emotional blur

The Washington Post report highlights reports of emotional flattening and reduced motivation—often called 'Ozempic personality'—among some GLP-1 drug users (e.g., Ozempic/Wegovy). While many patients see weight loss and mood benefits, clinicians have documented anecdotes of dulled joy and motivation that sometimes improve when doses are lowered. The exact cause is unclear, with hypotheses ranging from pharmacological effects on dopamine-related reward pathways to psychological and lifestyle factors. Large studies show associations with mental-health changes and potential overall benefits in some cases, but causation isn’t established. Safety and personalized care remain the priority as researchers gather more data.